Conquering Diseases

Study Of The Long-Term Safety Of A Drug Used To Treat Ulcerative Colitis (Us)

Description

Seeking adults who are being treated with the drug HUMIRA (Adalimumab) for their moderate to severe ulcerative colitis (UC) for a study of the long-term safety and effectiveness of the drug.

Overview

This is a registry of people who are taking the drug HUMIRA (Adalimumab) for their moderate to severe ulcerative colitis (UC). We are asking registry participants to provide us with contact information for their doctor and permission to contact their doctor once a year to have them fill out a questionnaire on their ulcerative colitis and use of HUMIRA.

What we're hoping for

We hope to evaluate the long-term safety and effectiveness of the drug HUMIRA (Adalimumab) for moderate to severe ulcerative colitis (UC).

Additional Information

ClinicalTrials.gov Identifier: NCT01848561

 Principal Investigator

Christopher  Marshall, MD

UMass Memorial Health Care

 Study Contact

Anne  Foley

Anne.foley@umassmemorial.org

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989